Skip to content
2000
Volume 26, Issue 1
  • ISSN: 1871-5249
  • E-ISSN: 1875-6166

Abstract

Introduction

Ischemic stroke remains one of the leading causes of death and physical and mental disability. Oxidative stress, free radicals, and inflammation play critical roles in ischemic brain damage. Free radical scavengers such as edaravone and dimethyl fumarate (DMF), known for their antioxidant and anti-inflammatory properties, are considered promising targets for ischemic stroke treatment. This study aimed to assess the impact of these drugs on brain ischemia.

Methods

Forty-nine rats were randomly divided into seven groups: sham, edaravone, and DMF controls, as well as edaravone, DMF 5, 15, and 30 groups. Middle cerebral artery occlusion (MCAO) was induced in all groups except the sham group. The MCAO groups were administered with either the vehicle, edaravone (3 mg/kg), or DMF at doses of 5, 15, and 30 mg/kg twice daily for 14 days. Neurobehavioral assessments were conducted throughout the experiment, and anatomical changes in the brain were evaluated using stereological methods.

Results

Edaravone and three doses of DMF improved neurobehavioral functions. All treated rats showed a reduction in the ischemic volume and cell loss in the brain regions when compared with the control animals. MCAO reduced the total number of neurons and just DMF doses had a significant effect on this factor. Interestingly, MCAO increased the number of non-neurons and only the DMF 30 group significantly decreased this parameter. DMF 30 was more effective in ischemic stroke.

Conclusion

Although edaravone improved neurological functions and reduced the size of brain ischemia and cell loss, DMF, especially at higher doses, exerted a more beneficial effect on these parameters. Therefore, DMF could be proposed as a reinforcement to currently conventional therapies.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/0118715249345683250116080547
2025-01-31
2026-03-06

  • From This Site

    /content/journals/cnsamc/10.2174/0118715249345683250116080547
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ThomT. HaaseN. RosamondW. HowardV.J. RumsfeldJ. ManolioT. ZhengZ.J. FlegalK. O’DonnellC. KittnerS. Lloyd-JonesD. GoffD.C.Jr HongY. AdamsR. FridayG. FurieK. GorelickP. KisselaB. MarlerJ. MeigsJ. RogerV. SidneyS. SorlieP. SteinbergerJ. Wasserthiel-SmollerS. WilsonM. WolfP. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation20061136e85e151 16407573
     [Google Scholar]
  2. ElkinsJ.S. JohnstonS.C. Thirty-year projections for deaths from ischemic stroke in the United States.Stroke20033492109211210.1161/01.STR.0000085829.60324.DE 12881608
     [Google Scholar]
  3. KikuchiK. MiuraN. KawaharaK.I. MuraiY. MoriokaM. LapchakP.A. TanakaE. Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke.Biomed. Rep.20131171210.3892/br.2012.7 24648884
     [Google Scholar]
  4. LapchakP.A. Development of thrombolytic therapy for stroke: A perspective.Expert Opin. Investig. Drugs200211111623163210.1517/13543784.11.11.1623 12437508
     [Google Scholar]
  5. YoshidaH. YanaiH. NamikiY. Fukatsu-SasakiK. FurutaniN. TadaN. Neuroprotective effects of edaravone: A novel free radical scavenger in cerebrovascular injury.CNS Drug Rev.200612192010.1111/j.1527‑3458.2006.00009.x 16834755
     [Google Scholar]
  6. LoveS. Oxidative stress in brain ischemia.Brain Pathol.19999111913110.1111/j.1750‑3639.1999.tb00214.x 9989455
     [Google Scholar]
  7. KikuchiK. KawaharaK. MiyagiN. UchikadoH. KuramotoT. MorimotoY. TancharoenS. MiuraN. TakenouchiK. OyamaY. ShresthaB. MatsudaF. YoshidaY. ArimuraS. MeraK. TadaK. YoshinagaN. MaenosonoR. OhnoY. HashiguchiT. MaruyamaI. ShigemoriM. Edaravone: A new therapeutic approach for the treatment of acute stroke.Med. Hypotheses201075658358510.1016/j.mehy.2010.07.038 20728280
     [Google Scholar]
  8. FloydR.A. Antioxidants, oxidative stress, and degenerative neurological disorders.Proc. Soc. Exp. Biol. Med.1999222323624510.1046/j.1525‑1373.1999.d01‑140.x 10601882
     [Google Scholar]
  9. AbeK. YukiS. KogureK. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.Stroke198819448048510.1161/01.STR.19.4.480 2834836
     [Google Scholar]
  10. OishiR. ItohY. NishiboriM. WatanabeT. NishiH. SaekiK. Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain.Stroke198920111557156410.1161/01.STR.20.11.1557 2815191
     [Google Scholar]
  11. ZhangN. Komine-KobayashiM. TanakaR. LiuM. MizunoY. UrabeT. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.Stroke200536102220222510.1161/01.STR.0000182241.07096.06 16166574
     [Google Scholar]
  12. LeeB.J. EgiY. van LeyenK. LoE.H. AraiK. Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro.Brain Res.20101307222710.1016/j.brainres.2009.10.026 19840779
     [Google Scholar]
  13. BannoM. MizunoT. KatoH. ZhangG. KawanokuchiJ. WangJ. KunoR. JinS. TakeuchiH. SuzumuraA. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia.Neuropharmacology200548228329010.1016/j.neuropharm.2004.10.002 15695167
     [Google Scholar]
  14. FengS. YangQ. LiuM. LiW. YuanW. ZhangS. WuB. LiJ. Edaravone for acute ischaemic stroke.Cochrane Database Syst. Rev.201112CD007230 22161410
     [Google Scholar]
  15. MrowietzU. AltmeyerP. BieberT. RöckenM. SchopfR.E. SterryW. Treatment of psoriasis with fumaric acid esters (Fumaderm®).J. Dtsch. Dermatol. Ges.20075871671710.1111/j.1610‑0387.2007.06346.x 17659047
     [Google Scholar]
  16. LinkerR.A. LeeD.H. RyanS. van DamA.M. ConradR. BistaP. ZengW. HronowskyX. BukoA. ChollateS. EllrichmannG. BrückW. DawsonK. GoelzS. WieseS. ScannevinR.H. LukashevM. GoldR. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.Brain2011134367869210.1093/brain/awq386 21354971
     [Google Scholar]
  17. ScannevinR.H. ChollateS. JungM. ShackettM. PatelH. BistaP. ZengW. RyanS. YamamotoM. LukashevM. RhodesK.J. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway.J. Pharmacol. Exp. Ther.2012341127428410.1124/jpet.111.190132 22267202
     [Google Scholar]
  18. AlbrechtP. BouchachiaI. GoebelsN. HenkeN. HofstetterH.H. IssbernerA. KovacsZ. LewerenzJ. LisakD. MaherP. MausbergA.K. QuasthoffK. ZimmermannC. HartungH.P. MethnerA. Effects of dimethyl fumarate on neuroprotection and immunomodulation.J. Neuroinflammation20129116310.1186/1742‑2094‑9‑163 22769044
     [Google Scholar]
  19. LeeD.H. GoldR. LinkerR.A. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: Therapeutic modulation via fumaric acid esters.Int. J. Mol. Sci.2012139117831180310.3390/ijms130911783 23109883
     [Google Scholar]
  20. IkedaS. HaradaK. OhwatashiA. KamikawaY. Effects of edaravone, a free radical scavenger, on photochemically induced cerebral infarction in a rat hemiplegic model.ScientificWorldJournal20132013117528010.1155/2013/175280 23853531
     [Google Scholar]
  21. Moharregh-KhiabaniD. LinkerR. GoldR. StangelM. Fumaric Acid and its esters: An emerging treatment for multiple sclerosis.Curr. Neuropharmacol.200971606410.2174/157015909787602788 19721818
     [Google Scholar]
  22. EllrichmannG. Petrasch-ParwezE. LeeD.H. ReickC. ArningL. SaftC. GoldR. LinkerR.A. Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington’s disease.PLoS One201161e1617210.1371/journal.pone.0016172 21297955
     [Google Scholar]
  23. KoizumiJ. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area.Jpn. J. Stroke1986818
     [Google Scholar]
  24. CulverJ.P. DurduranT. FuruyaD. CheungC. GreenbergJ.H. YodhA.G. Diffuse optical tomography of cerebral blood flow, oxygenation, and metabolism in rat during focal ischemia.J. Cereb. Blood Flow Metab.200323891192410.1097/01.WCB.0000076703.71231.BB 12902835
     [Google Scholar]
  25. TsudaK. Neuroprotective effects of MK-801 and catecholamine release in the central nervous system.Stroke2004355e96e9610.1161/01.STR.0000125718.25853.69 15060323
     [Google Scholar]
  26. NamavarM.R. RaminfardS. JahromiZ.V. AzariH. Effects of high-fat diet on the numerical density and number of neuronal cells and the volume of the mouse hypothalamus: A stereological study.Anat. Cell Biol.201245317818410.5115/acb.2012.45.3.178 23094206
     [Google Scholar]
  27. OwjfardM. BigdeliM.R. SafariA. NamavarM.R. Effects of nicorandil on neurobehavioral function, BBB integrity, edema and stereological parameters of the brain in the sub-acute phase of stroke in a rat model.J. Biosci.20204514910.1007/s12038‑020‑0021‑1 32345775
     [Google Scholar]
  28. MoutonP.R. Neurostereology: Unbiased stereology of neural systems.John Wiley & Sons2013
     [Google Scholar]
  29. GundersenH.J.G. JensenE.B.V. KiêuK. NielsenJ. The efficiency of systematic sampling in stereology — reconsidered.J. Microsc.1999193319921110.1046/j.1365‑2818.1999.00457.x 10348656
     [Google Scholar]
  30. CotterD. MackayD. FrangouS. HudsonL. LandauS. Cell density and cortical thickness in Heschl’s gyrus in schizophrenia, major depression and bipolar disorder.Br. J. Psychiatry2004185325825910.1192/bjp.185.3.258 15339832
     [Google Scholar]
  31. García-CabezasM.Á. JohnY.J. BarbasH. ZikopoulosB. Distinction of neurons, glia and endothelial cells in the cerebral cortex: An algorithm based on cytological features.Front. Neuroanat.20161010710.3389/fnana.2016.00107 27847469
     [Google Scholar]
  32. NamavarM.R. GhalavandiM. BahmanpourS. The effect of glutathione and buserelin on the stereological parameters of the hypothalamus in the cyclophosphamide-treated mice.J. Chem. Neuroanat.202011010187110.1016/j.jchemneu.2020.101871 33039509
     [Google Scholar]
  33. CsordásA. MázlóM. GallyasF. Recovery versus death of “dark” (compacted) neurons in non-impaired parenchymal environment: Light and electron microscopic observations.Acta Neuropathol.20031061374910.1007/s00401‑003‑0694‑1 12665989
     [Google Scholar]
  34. WangJ-Y. XiaQ. ChuK-T. PanJ. SunL-N. ZengB. ZhuY-J. WangQ. WangK. LuoB-Y. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: A widely used inhibitor of autophagy.J. Neuropathol. Exp. Neurol.201170431432210.1097/NEN.0b013e31821352bd 21412169
     [Google Scholar]
  35. FreretT. BouetV. Improvements of the Stroke Model Guidelines – Animal body weight and long-term functional concerns.J. Exp. Stroke Transl. Med.200922283110.6030/1939‑067X‑2.2.28
     [Google Scholar]
  36. SafariA. FazeliM. NamavarM.R. TanidehN. JafariP. Borhani-HaghighiA. Therapeutic effects of oral dimethyl fumarate on stroke induced by middle cerebral artery occlusion: An animal experimental study.Restor. Neurol. Neurosci.201735326527410.3233/RNN‑160670 28506000
     [Google Scholar]
  37. LinR. CaiJ. KostukE.W. RosenwasserR. IacovittiL. Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats.J. Neuroinflammation201613126910.1186/s12974‑016‑0733‑1 27733178
     [Google Scholar]
  38. ZhaoX. SunG. ZhangJ. TingS.M. GonzalesN. AronowskiJ. Dimethyl fumarate protects brain from damage produced by intracerebral hemorrhage by mechanism involving Nrf2.Stroke20154671923192810.1161/STROKEAHA.115.009398 25977275
     [Google Scholar]
  39. AhmadA. Moshahid KhanM. JavedH. RazaS.S. IshratT. Badruzzaman KhanM. SafhiM.M. IslamF. Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat.Mol. Cell. Biochem.20123671-221522510.1007/s11010‑012‑1335‑6 22648734
     [Google Scholar]
  40. YaoY. MiaoW. LiuZ. HanW. ShiK. ShenY. LiH. LiuQ. FuY. HuangD. ShiF.D. Dimethyl fumarate and monomethyl fumarate promote post-ischemic recovery in mice.Transl. Stroke Res.20167653554710.1007/s12975‑016‑0496‑0 27614618
     [Google Scholar]
  41. OwjfardM. BigdeliM.R. SafariA. NamavarM.R. Therapeutic effects of dimethyl fumarate on the rat model of brain ischemia.Braz. J. Pharm. Sci.202258e1967710.1590/s2175‑97902022e19677
     [Google Scholar]
  42. ClausenB.H. LundbergL. Yli-KarjanmaaM. MartinN.A. SvenssonM. AlfsenM.Z. FlængS.B. LyngsøK. Boza-SerranoA. NielsenH.H. HansenP.B. FinsenB. DeierborgT. IllesZ. LambertsenK.L. Fumarate decreases edema volume and improves functional outcome after experimental stroke.Exp. Neurol.201729514415410.1016/j.expneurol.2017.06.011 28602832
     [Google Scholar]
  43. KunzeR. UrrutiaA. HoffmannA. LiuH. HelluyX. PhamM. ReischlS. KorffT. MartiH.H. Dimethyl fumarate attenuates cerebral edema formation by protecting the blood–brain barrier integrity.Exp. Neurol.20152669911110.1016/j.expneurol.2015.02.022 25725349
     [Google Scholar]
  44. LiuL. VollmerM.K. KellyM.G. FernandezV.M. FernandezT.G. KimH. DoréS. Reactive Gliosis Contributes to Nrf2-Dependent Neuroprotection by Pretreatment with Dimethyl Fumarate or Korean Red Ginseng Against Hypoxic-Ischemia: Focus on Hippocampal Injury.Mol. Neurobiol.202057110511710.1007/s12035‑019‑01760‑0 31494826
     [Google Scholar]
  45. NakaseT. YoshiokaS. SuzukiA. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke.BMC Neurol.20111113910.1186/1471‑2377‑11‑39 21447190
     [Google Scholar]
  46. OwjfardM. BigdeliM.R. SafariA. HaghaniM. NamavarM.R. Effect of dimethyl fumarate on the motor function and spatial arrangement of primary motor cortical neurons in the sub-acute phase of stroke in a rat model.J. Stroke Cerebrovasc. Dis.202130410563010.1016/j.jstrokecerebrovasdis.2021.105630 33497934
     [Google Scholar]
  47. SafariA. Badeli-SarkalaH.II NamavarM.R. Kargar-AbarghoueiE. AnssariN. IzadiS. Borhani-HaghighiA. Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2.Curr. J. Neurol.201918310811310.18502/ijnl.v18i3.1633 31749931
     [Google Scholar]
  48. LiuL. VollmerM.K. AhmadA.S. FernandezV.M. KimH. DoréS. Pretreatment with Korean red ginseng or dimethyl fumarate attenuates reactive gliosis and confers sustained neuroprotection against cerebral hypoxic-ischemic damage by an Nrf2-dependent mechanism.Free Radic. Biol. Med.20191319811410.1016/j.freeradbiomed.2018.11.017 30458277
     [Google Scholar]
  49. MorrisG.P. WrightA.L. TanR.P. GladbachA. IttnerL.M. VisselB. A comparative study of variables influencing ischemic injury in the Longa and Koizumi methods of intraluminal filament middle cerebral artery occlusion in mice.PLoS One2016112e014850310.1371/journal.pone.0148503 26870954
     [Google Scholar]
  50. SarkalaH.B. JahanshahiM. DolatabadiL.K. NamavarM.R. Effect of G-CSF on the spatial arrangement of CA1 hippocampal pyramidal neurons after brain ischemia in the male rats.J. Chem. Neuroanat.201998808610.1016/j.jchemneu.2019.04.007 31005633
     [Google Scholar]
  51. JiaoL. ZhangJ. LiZ. LiuH. ChenY. XuS. Edaravone alleviates delayed neuronal death and long-dated cognitive dysfunction of hippocampus after transient focal ischemia in Wistar rat brains.Neuroscience201118217718310.1016/j.neuroscience.2011.01.017 21241778
     [Google Scholar]
  52. RagabD. AbdallahD.M. El-AbharH.S. The dual reno- and neuro-protective effects of dimethyl fumarate against uremic encephalopathy in a renal ischemia/reperfusion model.Pharmacol. Rep.202072496998310.1007/s43440‑020‑00076‑4 32141026
     [Google Scholar]
  53. MckeonR.J. HökeA. SilverJ. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars.Exp. Neurol.19951361324310.1006/exnr.1995.1081 7589332
     [Google Scholar]
  54. PerssonL. HårdemarkH.G. BolanderH.G. HilleredL. OlssonY. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats.Stroke198920564164510.1161/01.STR.20.5.641 2718205
     [Google Scholar]
  55. AldskogiusH. KozlovaE.N. Central neuron–glial and glial–glial interactions following axon injury.Prog. Neurobiol.199855112610.1016/S0301‑0082(97)00093‑2 9602498
     [Google Scholar]
  56. WilmsH. SieversJ. RickertU. Rostami-YazdiM. MrowietzU. LuciusR. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.J. Neuroinflammation201073010.1186/1742‑2094‑7‑30 20482831
     [Google Scholar]
  57. NishiH. WatanabeT. SakuraiH. YukiS. IshibashiA. Effect of MCI-186 on brain edema in rats.Stroke19892091236124010.1161/01.STR.20.9.1236 2505409
     [Google Scholar]
  58. KitagawaY. Edaravone in acute ischemic stroke.Intern. Med.200645522522610.2169/internalmedicine.45.0143 16595983
     [Google Scholar]
  59. HouX. XuH. ChenW. ZhangN. ZhaoZ. FangX. ZhangX. ChenH. XuY. Neuroprotective effect of dimethyl fumarate on cognitive impairment induced by ischemic stroke.Ann. Transl. Med.20208637510.21037/atm.2020.02.10 32355819
     [Google Scholar]
  60. ZhouX. ZhuL. WangL. GuoB. ZhangG. SunY. ZhangZ. LeeS.M-Y. YuP. WangY. Protective effect of edaravone in primary cerebellar granule neurons against iodoacetic acid-induced cell injury.Oxid. Med. Cell. Longev.2015201560698110.1155/2015/606981 26557222
     [Google Scholar]
  61. ArslanE.A. ArslanE. YamanS.O. KarahanS.C. The effects of edaravone on experimental brain ischemia/reperfusion injury in rats.Haydarpasa Numune Med J201959319720210.14744/hnhj.2019.15013
     [Google Scholar]
  62. FujiwaraN. SomA.T. PhamL-D. LeeB.J. MandevilleE.T. LoE.H. AraiK. A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.Neuroscience Letters201663371310.1016/j.neulet.2016.08.048
     [Google Scholar]
  63. Chen-RoetlingJ. ReganR.F. Targeting the Nrf2-heme oxygenase-1 axis after intracerebral hemorrhage.Curr. Pharm. Des.2017231522262237 27799046
     [Google Scholar]
/content/journals/cnsamc/10.2174/0118715249345683250116080547
Loading
Dimethyl Fumarate Attenuates Behavioral and Structural Impairments Associated with Brain Ischemia in Rats
Central Nervous System Agents in Medicinal Chemistry 26, 79 (2026); https://doi.org/10.2174/0118715249345683250116080547
/content/journals/cnsamc/10.2174/0118715249345683250116080547
/content/journals/cnsamc/10.2174/0118715249345683250116080547
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): brain ischemia; dimethyl fumarate; edaravone; Ischemic stroke; stereology; structural impairments

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test